The present invention relates to compounds according to general formula (I) to compositions, including a pharmaceutical formulation and a combination preparation comprising one or more of the compound (s) to a process for their preparation to uses thereof, including the use in the treatment or prevention of a viral infection or a Th17-associated inflammatory and/or autoimmune disease.
